
Biykem Bozkurt MD PhD, FHFSA, FACC, FAHA, FACP, FESC
Heart Failure & Transplantation
Senior Dean of Faculty, Mary and Gordon Cain Chair, Cardiology, Professor of Medicine, Director, Winters Center for Heart Failure, Associate Director, Cardiovascular Research Institute Baylor College of Medicine, Houston TX Past President of Heart Failure Society of America Editor-in-Chief, JACC: Heart Failure
Join to view full profile
2002 Holcombe BlvdMedvamc Cardiology Section-4C115BHouston, TX 77030
Phone+1 713-794-7070
Fax+1 713-794-7551
Dr. Bozkurt is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I serve as Senior Dean of Faculty at Baylor College of Medicine, where I oversee the Offices of Faculty Affairs, Faculty Development, the Center for Professionalism, and Community Engagement. I hold the Mary and Gordon Cain Chair and am a Professor of Medicine, Director of the Winters Center for Heart Failure, Associate Director of the Cardiovascular Research Institute, and Medical Care Line Executive Leader at the DeBakey VA Medical Center in Houston, Texas. I also serve as a member of the President’s Executive Leadership Team at Baylor College of Medicine.
Throughout my career, I have led change and excellence across all missions of academic medicine, including clinical care, research & education. I am recognized for my contributions to cardiology and heart failure. (Clarivate World’s Highly Cited Researcher (top 1% globally since 2018) with an H‑index of 100). My interests spans translational research, phase II–III clinical trials, and outcomes research. I previously served as President of the Heart Failure Society of America (2019–2020), chaired the 2021 Universal Definition and Classification of Heart Failure, and served as Vice Chair of the 2022 AHA/ACC Heart Failure Guidelines. I remain actively engaged in patient care, clinical research, and national and international scientific leadership.
I currently serve as Editor‑in‑Chief of JACC: Heart Failure, the highest‑impact journal in the field.
I have received recognition for excellence in clinical care, education, and leadership, including the ACC Proctor Harvey Young Teacher Award, the ACC Gifted Educator Award, Baylor Presidential Awards, the HFSA Distinguished Leadership Award (2024), the ACC Bahr Award of Excellence (2024), the ACC Distinguished Fellow Award (2025), and the AHA Laennec Clinician Educator Award (2025). I am honored to be invited to deliver keynote lectures and visiting professorships nationally & internationally.
Education & Training
UPMC Medical EducationFellowship, Advanced Heart Failure and Transplant Cardiology, 1996 - 1997
Baylor College of MedicineFellowship, Cardiovascular Disease, 1993 - 1996
Baylor College of MedicineResidency, Internal Medicine, 1990 - 1993
Istanbul University Istanbul Medical FacultyClass of 1989
Certifications & Licensure
TX State Medical License 1994 - 2028
PA State Medical License 1996 - 1998
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Recognized among the world's most influential researchers of the past decade, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year Web of Science, 2018-2025
- President Heart Failure Society of America, 2019
- Ben and Margaret Love Foundation Bobby Alford Presidential Award for Academic Clinical Professionalism Baylor College of Medicine, 2019
Clinical Trials
- Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure
- LINK-HF2 - Remote Monitoring Analytics in Heart Failure Start of enrollment: 2021 Apr 19
Publications & Presentations
PubMed
- Artificial Intelligence-Enabled Detection and Management of Physiological Instability in Heart Failure: Results of the Randomized LINK-HF2 Trial.Konstantinos Sideris, Carsten Schmalfuss, Neil Lewis, Karim Sallam, Biykem Bozkurt
JACC. Heart Failure. 2026-10-09 - Defining Clinically Meaningful Within-Patient Changes in Heart Failure: JACC: Heart Failure Position Statement.Amin Yehya, Rebecca Hahn, Barry Borlaug, Victoria Delgado, Andrew Ambrosy
JACC. Heart Failure. 2026-10-01 - 3 citationsRisk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD.L Parker Gregg, Biykem Bozkurt, Sankar D Navaneethan
Clinical Journal of the American Society of Nephrology. 2026-10-01
Authored Content
- Cardiac Transplant Patients Should Receive a Booster for COVID-19 VaccinationAugust 2021
Press Mentions
Old Drugs, New Tricks: DECISION and Other Trials Inform on Cardiac Glycosides in HFMay 22nd, 2026
ACC CardiaCast: The Role of MRAs in the Management of HFNovember 6th, 2025
Trial Data Support in-Hospital Initiation of SGLT2 Inhibitors for Heart FailureSeptember 12th, 2025
Professional Memberships
- Member
- Member
- Heart Failure Society of AmericaPresident
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: